The Journal of Pediatrics
Volume 149, Issue 6 , Pages 755-762.e1 , December 2006

Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season

Received 19 November 2005 ,Revised 15 March 2006 ,Accepted 16 June 2006.

References 

  1. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232–239
  2. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53:1–40
  3. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113:1758–1764
  4. Neuzil KM, Wright PF, Mitchel EF, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856–864
  5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231
  6. Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185:147–152
  7. O’Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113:585–593
  8. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics. 2004;113:1441–1447
  9. Boyer KM, Cherry JD, Wright PF, Lerman SJ, Gross PA, Foy HM, et al. Clinical reactions and serologic responses in healthy children aged 6 to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccines. J Infect Dis. 1977;136(Suppl):S579–S583
  10. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005;115:1039–1047
  11. Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child. 2000;83:488–491
  12. Hoberman A, Greenberg DP, Paradise JL, Rockette HE, Lave JR, Kearny DH, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608–1616
  13. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23:189–197
  14. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365:773–780
  15. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 versus 2 doses. Pediatrics. 2005;116:153–159
  16. Navarro-Mari JM, Perez-Ruiz M, Cantudo-Munoz P, Petit-Gancedo C, Jimenez-Valera M, Rosa-Fraile M. Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study. J Clin Epidemiol. 2005;58:275–279
  17. Principi N, Esposito S, Gasparini R, Marchisio P, Crovari P. Burden of influenza in healthy children and their households. Arch Dis Child. 2004;89:1002–1007
  18. Kempe A, Daley MF, Barrow J, Allred N, Hester N, Beaty BL, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005;115:146–154
  19. US Department of Health and Human Services. The international classification of diseases, 9th revision, clinical modification. Washington, DC: US Government Printing Office; 2002;
  20. Daley MF, Barrow J, Pearson K, Crane LA, Gao D, Stevenson JM, et al. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics. 2004;113:e26–e33
  21. American Medical Association. Current procedural terminology: CPT 2002 standard edition. Chicago, IL: American Medical Association; 2002;
  22. Colorado Department of Public Health and Environment. Summary of the 2003-04 influenza season. Available at http://www.cdphe.state.co.us/dc/Influenza/summary_0304%20.html. Accessed September 21, 2005.
  23. Robinson C. Contagious comments: bug watch. Available at http://www.thechildrenshospital.org/pro/publications/. Accessed November 15, 2005.
  24. Centers for Disease Control and Prevention (CDC). Respiratory syncytial virus activity: United States, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004;53:1159–1160
  25. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21:333–339
  26. Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines: 1978. Rev Infect Dis. 1983;5:737–747
  27. Kunzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine. 1996;14:1108–1110
  28. Allison PA. Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute, Inc; 1995;
  29. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001;20:733–740
  30. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68–76
  31. Smits AJ, Hak E, Stalman WA, van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect. 2002;128:205–211
  32. Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Tsuchimoto T, et al. A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine. 2003;21:4507–4513
  33. Hurwitz ES, Haber M, Chang A, Shope T, Teo ST, Giesick JS, et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis. 2000;182:1218–1221
  34. Ruest A, Michaud S, Deslandes S, Frost EH. Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol. 2003;41:3487–3493
  35. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166–1169
  36. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247
  37. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev. 1988;10:212–241
  38. Maeda T, Shintani Y, Nakano K, Terashima K, Yamada Y. Failure of inactivated influenza A vaccine to protect healthy children age 6-24 months. Pediatr Int. 2004;46:122–125
  39. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:RR-7
  40. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49:RR-9

 Funding for this project was provided by a cooperative agreement with the Centers for Disease Control and Prevention (CDC) through the Association of American Medical Colleges (AAMC) (grant MM-0752-04/04). The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the AAMC. Dr. Allison was also supported by a National Research Service Award (grant T32 HP10006).

PII: S0022-3476(06)00578-6

doi: 10.1016/j.jpeds.2006.06.036

The Journal of Pediatrics
Volume 149, Issue 6 , Pages 755-762.e1 , December 2006

Article Tools

* Image Usage & Resolution